John Overdeck’s iShares Russell Top 200 Growth ETF IWY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$232K Sell
800
-301,200
-100% -$85M ﹤0.01% 4688
2026
Q1
$75.1M Buy
302,000
+32,760
+12% +$8.68M 0.06% 363
2025
Q4
$74.6M Buy
269,240
+267,740
+17,849% +$74.2M 0.11% 244
2025
Q3
$410K Sell
1,500
-293,000
-99% -$75.8M ﹤0.01% 3078
2025
Q2
$72.6M Sell
294,500
-125,200
-30% -$27.9M 0.13% 206
2025
Q1
$88.5M Buy
419,700
+122,800
+41% +$28.3M 0.19% 129
2024
Q4
$69.9M Buy
296,900
+59,200
+25% +$13.6M 0.15% 159
2024
Q3
$52.3M Buy
237,700
+200,100
+532% +$42.6M 0.11% 213
2024
Q2
$8.07M Sell
37,600
-70,700
-65% -$14.1M 0.02% 797
2024
Q1
$21.1M Buy
108,300
+5,600
+5% +$1.05M 0.05% 428
2023
Q4
$18M Buy
102,700
+10,400
+11% +$1.71M 0.04% 451
2023
Q3
$14.2M Buy
+92,300
New +$14.7M 0.04% 475

Other funds holding IWY

John Overdeck's IWY Position: Q2 2026 in Review

John Overdeck reduced its iShares Russell Top 200 Growth ETF (IWY) stake by 100% in Q2 2026, selling an estimated $85M and leaving 800 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #4688.

John Overdeck first reported a position in IWY in Q3 2023 and has held it in 12 quarters since. The position peaked at $88.5M in Q1 2025. 681 funds tracked by Wall St. Rank hold IWY as of Q2 2026.

  • John Overdeck held 800 shares of iShares Russell Top 200 Growth ETF worth $232K as of Q2 2026.
  • John Overdeck sold 301,200 iShares Russell Top 200 Growth ETF shares in Q2 2026, an estimated $85M.
  • iShares Russell Top 200 Growth ETF made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4688 holding.
  • John Overdeck first reported a position in iShares Russell Top 200 Growth ETF in Q3 2023 and has held it in 12 quarters since.
  • John Overdeck's iShares Russell Top 200 Growth ETF position peaked at $88.5M in Q1 2025.
  • 681 funds tracked by Wall St. Rank held iShares Russell Top 200 Growth ETF as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.